Hillrom faces lawsuit after dropping planned $375M Bardy Diagnostics deal
Hillrom axed plans to acquire cardiac monitoring company Bardy Diagnostics over reimbursement changes by a Medicare contractor. Bardy filed suit against Hillrom on Sunday.
Hillrom to buy cardiac monitoring company Bardy Diagnostics for $375M
Hillrom will buy Bardy Diagnostics, a startup that makes a wearable ECG patch, for $375 million in cash.
Integrating GLP-1s: How Berry Street is Redefining Nutrition Care
Richard Fu details the company's approach to nutrition therapy and strategy for patients using GLP-1s.